Targeted inactivation of the neurotensin type 1 receptor reveals its role in body temperature control and feeding behavior but not in analgesia

Brain Research

Volumn 953, Issue 1-2, 2002, Pages 63-72

  Remaury, Anne ^a   Vita, Natalio ^a   Gendreau, Sylvain ^a   Jung, Mireille ^a   Arnone, Michelle ^a   Poncelet, Martine ^a   Culouscou, Jean Michel ^a   Le Fur, Gérard ^a   Soubrié, Philippe ^a   Caput, Daniel ^a   Shire, David ^a   Kopf, Manfred ^b   Ferrara, Pascual ^a  

^a SANOFI   (France)

^b ETH ZURICH   (Switzerland)

Author keywords

Analgesia; Feeding; Hypolocomotion; Hypothermia; Knockout mouse; Neurotensin receptor; Weight control

Indexed keywords

APPETITE STIMULANT; NALOXONE; NEUROPEPTIDE Y; NEUROTENSIN RECEPTOR; PHENYLQUINONE;

ANALGESIA; ANIMAL EXPERIMENT; ARTICLE; BODY TEMPERATURE; CONTROLLED STUDY; FEEDING BEHAVIOR; FEMALE; FERTILITY; FOOD INTAKE; HYPERTHERMIA; HYPOTHERMIA; LOCOMOTION; MALE; MOUSE; NONHUMAN; PERINATAL PERIOD; PRIORITY JOURNAL; WEIGHT GAIN; WILD TYPE; WRITHING TEST;

ANALGESICS; ANIMALS; BODY TEMPERATURE REGULATION; FEEDING BEHAVIOR; FEMALE; GENE DELETION; HYPOTHERMIA; INJECTIONS, INTRAVENTRICULAR; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MOTOR ACTIVITY; NEUROPEPTIDE Y; NEUROTENSIN; PAIN; RECEPTORS, NEUROTENSIN;

EID: 0037145699     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(02)03271-7     Document Type: Article

References (44)

1. Beck B. Neuropeptides and obesity. Nutrition. 16:2000;916-923.
2. Beck B., Stricker-Krongrad A., Richy S., Burlet C. Evidence that hypothalamic neurotensin signals leptin effects on feeding behavior in normal and fat-preferring rats. Biochem. Biophys. Res. Commun. 252:1998;634-638.
3. Bissette G., Nemeroff C.B., Loosen P.T., Prange A.J. Jr., Lipton M.A. Hypothermia and intolerance to cold induced by intracisternal administration of the hypothalamic peptide neurotensin. Nature. 262:1976;607-609.
4. Carraway R., Leeman S.E. The isolation of a new hypotensive peptide, neurotensin, from bovine hypothalami. J. Biol. Chem. 248:1973;6854-6861.
5. Clark J.T., Kalra P.S., Crowley W.R., Kalra S.P. Neuropeptide Y and human pancreatic polypeptide stimulate feeding behavior in rats. Endocrinology. 115:1984;427-429.
6. Clineschmidt B.V., McGuffin J.C., Bunting P.B. Neurotensin: antinocisponsive action in rodents. Eur. J. Pharmacol. 54:1979;129-139.
7. Dobner P.R., Fadel J., Deitemeyer N., Carraway R.E., Deutch A.Y. Neurotensin-deficient mice show altered responses to antipsychotic drugs. Proc. Natl. Acad. Sci. USA. 98:2001;8048-8053.
8. Dubuc I., Costentin J., Terranova J.P., Barnouin M.C., Soubrié P., Le Fur G., Rostène W., Kitabgi P. The nonpeptide neurotensin antagonist, SR 48692, used as a tool to reveal putative neurotensin receptor subtypes. Br. J. Pharmacol. 112:1994;352-354.
9. Dubuc I., Sarret P., Labbe-Jullie C., Botto J.M., Honore E., Bourdel E., Martinez J., Costentin J., Vincent J.P., Kitabgi P., Mazella J. Identification of the receptor subtype involved in the analgesic effect of neurotensin. J. Neurosci. 19:1999;503-510.
10. Ehlers R.A., Kim S.H., Zhang Y.J., Ethridge R.T., Murrilo C., Hellmich M.R., Evans D.B., Townsend C.M., Evers B.M. Gut peptide receptor expression in human pancreatic cancers. Ann. Surg. 231:2000;838-846.
11. Evers B.M., Bold R.J., Ehrenfried J.A., Li J., Townsend C.M., Klimpel G.R. Characterization of functional neurotensin receptors on human lymphocytes. Surgery. 116:1994;134-140.
12. Gully D., Canton M., Boigegrain R., Jeanjean F., Molimard J.-C., Poncelet M., Gueudet C., Heaulme M., Leyris R., Brouard A., Pelaprat D., Labbé-Jullié C., Mazella J., Soubrié P., Maffrand J.-P., Rostène W., Kitabgi P., Le Fur G. Biochemical and pharmacological profile of a potent and selective nonpeptide antagonist of the neurotensin receptor. Proc. Natl. Acad. Sci. USA. 90:1993;65-69.
13. Haley T.J., McCormick W.G. Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse. Br. J. Pharmacol. Chemother. 12:1957;12-15.
14. Kitabgi P., Checler F., Mazella J., Vincent J.P. Pharmacology and biochemistry of neurotensin receptors. Rev. Clin. Basic Pharmacol. 5:1985;397-486.
15. Laurent P., Clerc P., Mattei M.G., Forgez P., Dumont X., Ferrara P., Caput D., Rostène W. Chromosomal localization of mouse and human neurotensin receptor genes. Mamm. Genome. 5:1994;303-306.
16. Lépée-Lorgeoux I., Betancur C., Rostène W., Pélaprat D. Differential ontogenetic patterns of levocabastine-sensitive neurotensin NT2 receptors and of NT1 receptors in the rat brain revealed by in situ hybridization. Dev. Brain Res. 113:1999;115-131.
17. Mai J.K., Triepel J., Metz J. Neurotensin in the human brain. Neuroscience. 22:1987;499-524.
18. Mazella J., Botto J.M., Guillemare E., Coppola T., Sarret P., Vincent J.P. Structure, functional expression, and cerebral localization of the levocabastine-sensitive neurotensin/neuromedin n receptor from mouse brain. J. Neurosci. 16:1996;5613-5620.
19. Mazella J., Zsurger N., Navarro V., Chabry J., Kaghad M., Caput D., Ferrara P., Vita N., Gully D., Maffrand J.P., Vincent J.P. The 100-kDa neurotensin receptor is gp95/sortilin, a non-g-protein-coupled receptor. J. Biol. Chem. 273:1998;26273-26276.
20. Mercer J.G., Hoggard N., Williams L.M., Lawrence C.B., Hannah L.T., Trayhurn P. Localization of leptin receptor mRNA and the long form splice variant (Ob-Rb) in mouse hypothalamus and adjacent brain regions by in situ hybridization. FEBS Lett. 387:1996;113-116.
21. Nemeroff C.B. The interaction of neurotensin with dopaminergic pathways in the central nervous system: basic neurobiology and implications for the pathogenesis and treatment of schizophrenia. Psychoneuroendocrinology. 11:1986;15-37.
22. Nemeroff C.B., Osbahr A.J. III, Manberg P.J., Ervin G.N., Prange A.J. Jr. Alterations in nociception and body temperature after intracisternal administration of neurotensin, beta-endorphin, other endogenous peptides, and morphine. Proc. Natl. Acad. Sci. USA. 76:1979;5368-5371.
23. Nicot A., Rowe W.B., De Kloet E.R., Betancur C., Jessop D.S., Lightman S.L., Quirion R., Rostene W., Berod A. Endogenous neurotensin regulates hypothalamic-pituitary-adrenal axis activity and peptidergic neurons in the rat hypothalamic paraventricular nucleus. J. Neuroendocrinol. 9:1997;263-269.
24. Nitschke L., Kopf M., Lamers M.C. Quick nested PCR screening of ES cell clones for gene targeting events. BioTechniques. 14:1993;914-916.
25. Palacios J.M., Pazos A., Dietl M.M., Schlumpf M., Lichtensteiger W. The ontogeny of brain neurotensin receptors studied by autoradiography. Neuroscience. 25:1988;307-317.
26. Pearson H. Surviving a knockout blow. Nature. 415:2002;8-9.
27. Pettibone D.J., Hess J.F., Hey P.J., Jacobson M.A., Leviten M., Lis E.V., Mallorga P.J., Pascarella D.M., Snyder M.A., Williams J.B., Zeng Z. The effects of deleting the mouse neurotensin receptor NTR1 on central and peripheral responses to neurotensin. J. Pharmacol. Exp. Ther. 300:2002;305-313.
28. Pugsley T.A., Akunne H.C., Whetzel S.Z., Demattos S., Corbin A.E., Wiley J.N., Wustrow D.J., Wise L.D., Heffner T.G. Differential effects of the nonpeptide neurotensin antagonist, SR 48692, on the pharmacological effects of neurotensin agonists. Peptides. 16:1995;37-44.
29. Richard F., Barroso S., Martinez J., Labbé-Jullié C., Kitabgi P. Agonism, inverse agonism, and neutral antagonism at the constitutively active human neurotensin receptor 2. Mol. Pharmacol. 60:2001;1392-1398.
30. Rostène W.H., Alexander M.J. Neurotensin and neuroendocrine regulation. Front. Neuroendocrinol. 18:1997;115-173.
31. Sahu A., Carraway R.E., Wang Y.P. Evidence that neurotensin mediates the central effect of leptin on food intake in rat. Brain Res. 888:2001;343-347.
32. Sato M., Kiyama H., Tohyama M. Different postnatal development of cells expressing mRNA encoding neurotensin receptor. Neuroscience. 48:1992;137-149.
33. Stanley B.G., Hoebel B.G., Leibowitz S.F. Neurotensin: effects of hypothalamic and intravenous injections on eating and drinking in rats. Peptides. 4:1983;493-500.
34. Tanaka K., Masu M., Nakanishi S. Structure and functional expression of the cloned rat neurotensin receptor. Neuron. 4:1990;847-854.
35. Thor K., Rosell S. Neurotensin increases colonic motility. Gastroenterology. 90:1986;27-31.
36. Tyler-McMahon B.M., Stewart J.A., Farinas F., McCormick D.J., Richelson E. Highly potent neurotensin analog that causes hypothermia and antinociception. Eur. J. Pharmacol. 390:2000;107-111.
37. Tyler B.M., Cusack B., Douglas C.L., Souder T., Richelson E. Evidence for additional neurotensin receptor subtypes: neurotensin analogs that distinguish between neurotensin-mediated hypothermia and antinociception. Brain Res. 792:1998;246-252.
38. Tyler B.M., McCormick D.J., Hoshall C.V., Douglas C.L., Jansen K., Lacy B.W., Cusack B., Richelson E. Specific gene blockade shows that peptide nucleic acids readily enter neuronal cells in vivo. FEBS Lett. 421:1998;280-284.
39. Vincent J.P., Mazella J., Kitabgi P. Neurotensin and neurotensin receptors. Trends Pharmacol. Sci. 20:1999;302-309.
40. Vita N., Laurent P., Lefort S., Chalon P., Dumont X., Kaghad M., Gully D., Le Fur G., Ferrara P., Caput D. Cloning and expression of a complementary DNA encoding a high affinity human neurotensin receptor. FEBS Lett. 317:1993;139-142.
41. 2 receptor expressed in Chinese hamster ovary cells. Eur. J. Pharmacol. 360:1998;265-272.
42. Watts A.G., Sanchez-Watts G., Kelly A.B. Distinct patterns of neuropeptide gene expression in the lateral hypothalamic area and arcuate nucleus are associated with dehydration-induced anorexia. J. Neurosci. 19:1999;6111-6121.
43. Yamada M., Lombet A., Forgez P., Rostène W. Distinct functional characteristics of levocabastine sensitive rat neurotensin nt2 receptor expressed in chinese hamster ovary cells. Life Sci. 62:1998;L375-L380.
44. Zsürger N., Chabry J., Coquerel A., Vincent J.P. Ontogenesis and binding properties of high-affinity neurotensin receptors in human brain. Brain Res. 586:1992;303-310.